All News about Cti Biopharm Corp
![](https://cdn.benzinga.com/files/images/story/2022/05/13/mid-day_movers_image.jpg?width=1200&height=800&fit=crop)
![](https://www.financialnewsmedia.com/wp-content/uploads/2020/12/BIOV.small_.jpg)
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech5_2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3665.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3462.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_404.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3421.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_402.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-gdd37bc5d2_1920_14.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3678.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_401.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3316.jpeg)
![](https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2012/biotech3_3.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech3_3.jpg)
![](/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_5471.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-g91232d1d0_1920.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/penny-stocks-insider-trade_78.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_341.png)
61 Biggest Movers From Yesterday
December 02, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-afternoon-market-update_78.jpg)
Mid-Afternoon Market Update: Dow Rises Over 100 Points; CTI BioPharma Shares Plummet
December 01, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://g.foolcdn.com/editorial/images/655442/fda-blocks.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_5318.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-morning-market-update_78.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/nerve-cell-2213009_1920_36.jpg)
Via Benzinga
Topics
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_69.jpg)
50 Stocks Moving In Wednesday's Mid-Day Session
December 01, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.